RK
Rohan KordeFund Manager Since 11 Nov 2021
EquitySector - Healthcare
ITI Pharma and Healthcare Fund Direct Growth
3Y Annualised
20.42%
-0.00% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-4.59%
-0.00% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
3 years 9 months
NIFTY 50
7 years 5 months
FD
9 years 7 months
Fund info
Fund size
₹221.78 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Nippon India Nifty Pharma ETF
-3.15%
2nd
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
-3.20%
3rd
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
-3.20%
4th
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
-3.21%
5th
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
-3.30%
54th
ITI Pharma and Healthcare Fund Direct Growth
-4.59%
Fund Managers
PA
Pratibh AgarwalFund Manager Since 29 Apr 2022
HG
Hetal GadaFund Manager Since 29 Apr 2022
About ITI Pharma and Healthcare Fund Direct Growth
ITI Pharma and Healthcare Fund Direct Growth is a Equity mutual fund scheme from ITI Asset Management Limited. This fund has been in existence for 4 years, having been launched on 2021-11-11. ITI Pharma and Healthcare Fund Direct Growth has ₹221.78 Cr worth of assets under management (AUM) as of Thu Apr 02 2026. The latest Net Asset Value (NAV) of ITI Pharma and Healthcare Fund Direct Growth as of Tue Mar 31 2026 is ₹16.0904. The fund has an expense ratio of 0.47%, which is medium comparable to most other Equity funds.
ITI Pharma and Healthcare Fund Direct Growth returns for the last 1 year are -4.05%. Since launch, it has delivered 11.45% average annual returns.
The ITI Pharma and Healthcare Fund Direct Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of ITI Pharma and Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 11.12%
- Divi's Laboratories Ltd: 9.01%
- Apollo Hospitals Enterprise Ltd: 6.62%
- Max Healthcare Institute Ltd Ordinary Shares: 5.94%
- Torrent Pharmaceuticals Ltd: 5.17%
AMC Information
| Name | ITI Asset Management Limited |
|---|---|
| Founding Date | 2021-11-11 |
| mfassist@itiorg.com | |
| Phone | 022-66214999 |
| Website | www.itimf.com |
| Address | Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road |
Tax Implications of ITI Pharma and Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from ITI Asset Management Limited
ITI Arbitrage Fund Regular Growth
Alternative StrategiesArbitrage Fund
3Y CAGR
6.93%
expense ratio
0.93%
fund size
₹48.75 Cr
ITI Arbitrage Fund Direct Growth
Alternative StrategiesArbitrage Fund
3Y CAGR
7.71%
expense ratio
0.21%
fund size
₹48.75 Cr
ITI Liquid Fund Regular Growth
Capital PreservationLiquid
3Y CAGR
6.58%
expense ratio
0.25%
fund size
₹55.79 Cr
ITI Liquid Fund Direct Growth
Capital PreservationLiquid
3Y CAGR
6.75%
expense ratio
0.09%
fund size
₹55.79 Cr
ITI Multi Cap Fund Direct Growth
EquityMulti-Cap
3Y CAGR
18.09%
expense ratio
0.33%
fund size
₹1336.69 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
